TP53 and cancer: A recent study has shed light on the mechanisms of metabolic reprogramming in cancer cells, highlighting the role of key signaling pathways—such as Reactive Oxygen Species (ROS), AMP-activated Protein Kinase (AMPK), Mitogen-activated Protein Kinase (MAPK), Phosphoinositide 3-kinase (PI3K), Hypoxia-inducible Factor 1α (HIF-1α), and Tumor Protein p53 (p53)—in regulating metabolic processes like glucose, lipid, and amino acid metabolism.